3,000
Participants
Start Date
May 30, 2018
Primary Completion Date
February 1, 2019
Study Completion Date
April 30, 2019
biotin
This is a national, academic, observational and retrospective study comparing one group of progressive MS patients with high dose biotin to another group without this treatment using a propensity score, in intention to treat.
propensity score
This is a national, academic, observational and retrospective study comparing one group of progressive MS patients with high dose biotin to another group without this treatment using a propensity score, in intention to treat.
CHU Clermont-FERRAND, Clermont-Ferrand
Collaborators (1)
OFSEP (Observatoire Français de la Sclérose en Plaques)
UNKNOWN
SFSEP (Société Francophone de la Sclérose en Plaques)
UNKNOWN
MedDay Pharmaceuticals SA
INDUSTRY
University Hospital, Clermont-Ferrand
OTHER